Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GMRx2 vs Dual Combinations in Hypertension
NCT04518293Phase 3Completed
- Sponsor
- George Medicines
- Start
- Jul 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of telmisartan, amlodipine, indapamide in hypertension (HTN), sponsored by George Medicines. Started Jul 2021; status: completed.
02
Drugs
telmisartanamlodipineindapamide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04518293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04518293.